# Impact of NOL Intraoperative Guided Fentanyl Analgesia vs SCC for Elective Major Abdominal Surgery

> **NCT03970291** · NA · COMPLETED · sponsor: **Medasense Biometrics Ltd** · enrollment: 95 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DEVICE:** PMD-200

## Key facts

- **NCT ID:** NCT03970291
- **Lead sponsor:** Medasense Biometrics Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2021-05-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2022-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03970291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03970291, "Impact of NOL Intraoperative Guided Fentanyl Analgesia vs SCC for Elective Major Abdominal Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03970291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*